The retail investors and the note-holders are basically screwed due to one specific thing called "SALES". In BioElectronics case it's due to the lack of "SALES", which management bet wouldn't happen. Now they're down to no cash, or I should say 6K doesn't go very far now days.
Operating loans due the end of this year plus going into next will put an even tighter squeeze on the PPS.
Declining Sales Cheers!~~
Bearish
Everything I say and write is my opinion and my opinion only. Do your own due diligence when investing